<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Satsuma Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Satsuma Pharmaceuticals, Inc.

    With operations in South San Francisco, CA and Research Triangle Park, NC, Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing STS101 (dihydroergotamine mesylate (DHE) nasal powder) as an important and differentiated therapeutic option for the acute treatment of migraine. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $249,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      John Kollins
    • FOUNDED
      2016
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Shionogi & Co. Ltd.

    Shionogi & Co. Ltd.

    Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, an...

    Shionogi & Co., Ltd. engages in the research, d...

    Filing Type:    PU
    Abeona Therapeutics, Inc.

    Abeona Therapeutics, Inc.

    Abeona Therapeutics is focused on developing and delivering gene therapy products ...

    Abeona Therapeutics is focused on developing an...

    Filing Type:    PU
    Alzamend Neuro, Inc

    Alzamend Neuro, Inc

    Alzamend Neuro™, Inc. (“Alzamend™”) is a biotechnology company dedicated t...

    Alzamend Neuro™, Inc. (“Alzamend™”) is ...

    Filing Type:    RA
    ACADIA Pharmaceuticals

    ACADIA Pharmaceuticals

    At ACADIA (NASDAQ: ACAD), we share a passion for improving the lives of patients w...

    At ACADIA (NASDAQ: ACAD), we share a passion fo...

    Filing Type:    PU
    Replimune Group, Inc.

    Replimune Group, Inc.

    Cancer is one of the most difficult diseases to treat. It is constantly changing, ...

    Cancer is one of the most difficult diseases to...

    Filing Type:    PU
    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suff...

    Marinus Pharmaceuticals, Inc. is committed to i...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.